Skip to content
value.today

SteadyMed Ltd.

Total raised
$51 M
2 rounds on record
Latest round
$30 M
Apr 2017
First round on record
Aug 2016
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of SteadyMed Ltd.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2017$30 MNo. 2$10 to $50 million

SteadyMed Ltd.: Raise no. 2, Apr 2017

Investors in this round

19 investors had bought by the notice of May 8, 2017: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for SteadyMed Ltd. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,725,073
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Israel

People named in the notice

  • David W. Nassif · Executive Officer
  • Jonathan Rigby · Executive Officer, Director
  • Brian W. Stark · Director
  • Donald W. Huffman · Director
  • Elizabeth W. Cermak · Director
  • Keith W. Bank · Director
  • Ron W. Ginor · Director
  • Stephen W. Farr · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • JMP Securities LLC (CRD 22208) · San Francisco, CaliforniaSold in all US states
  • H.C. Wainwright & Co. (CRD 375) · New York, New YorkSold in all US states

Signed by David W. Nassif, Chief Financial Officer. Source: SEC Form D, newest notice filed May 8, 2017. Read the notice at the SEC.

equity, optionsSEC
Aug 2016$21 MNo. 1$10 to $50 million

SteadyMed Ltd.: Raise no. 1, Aug 2016

Investors in this round

13 investors had bought by the notice of Aug 17, 2016: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for SteadyMed Ltd. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$21 M of $32 M offered; $11 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,236,666
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Israel

People named in the notice

  • David W. Nassif · Executive Officer
  • Jonathan Rigby · Executive Officer, Director
  • Brian W. Stark · Director
  • Donald W. Huffman · Director
  • Elizabeth W. Cermak · Director
  • Keith W. Bank · Director
  • Ron W. Ginor · Director
  • Stephen W. Farr · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann Financial Services, Inc. · broker-dealer Ladenburg Thalmann & Co., Inc. (CRD 505) · New York, New YorkSold in all US states
  • H.C. Wainwright & Co. (CRD 375) · New York, New YorkSold in all US states
  • JMP Securities LLC (CRD 22208) · San Francisco, CaliforniaSold in all US states

Signed by David Nassif, EVP and CFO. Source: SEC Form D, newest notice filed Aug 17, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • SteadyMed Ltd. chose not to state its revenue in its newest notice of a funding round (May 2017).

    SEC Form D · May 2017

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · May 2017

That is all the official record says: SteadyMed Ltd. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

8 named in official filings. Open an investor to see everything it has backed.

Investors in SteadyMed Ltd.
InvestorKindAmountRoundRoleSource
Bank KeithOthernot statednot statedHeld Series A-2, B, D and E preferred stock, 10% owner, director (Form 3, 2015)SEC Form 3
Brian Jay StarkPersonnot statednot statedHeld Series B, C, D and E preferred stock, 10% owner, director (Form 3, 2015)SEC Form 3
Deerfield Management Company, L.P.Fund or asset managernot statednot statedHeld Series E preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Deerfield Mgmt III, L.P.Fund or asset managernot statednot statedHeld Series E preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Deerfield Mgmt L.P.Fund or asset managernot statednot statedHeld Series E preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Deerfield Private Design Fund III, L.P.Fund or asset managernot statednot statedHeld Series E preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Deerfield Special Situations Fund, L.P.Fund or asset managernot statednot statedHeld Series E preferred stock, 10% owner (Form 3, 2015)SEC Form 3
SteadyMed Investors, LLCFund or asset managernot statednot statedHeld Series A-2, B, D and E preferred stock, 10% owner (Form 3, 2015)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by SteadyMed Ltd.
NameRoleNamed in
David W. NassifExecutive officerMay 2017
Jonathan RigbyExecutive officerMay 2017
Brian W. StarkDirectorMay 2017
Donald W. HuffmanDirectorMay 2017
Elizabeth W. CermakDirectorMay 2017
Jonathan RigbyDirectorMay 2017
Keith W. BankDirectorMay 2017
Ron W. GinorDirectorMay 2017
Stephen W. FarrDirectorMay 2017